Výsledky vyhledávání - "Crossman David C"

Akademický článek

Study protocol: a randomised controlled trial investigating the effect of exercise training on peripheral blood gene expression in patients with stable angina

Autor: Crossman David C, Milo Marta, Tew Garry A, Bourke Liam, Saxton John M, Chico Timothy JA

Publikováno v: BMC Public Health, Vol 10, Iss 1, p 620 (2010)

Abstract Background Exercise training has been shown to reduce angina and promote collateral vessel development in patients with coronary artery disease. However, the mechanism whereby exercise exerts these beneficial effects is unclear. There has be

Externí odkaz: https://doaj.org/article/5bcaf3a2393541b39250fabe3b759c39

Zobrazit plný text záznamu

Akademický článek

Genetic and functional association of FAM5C with myocardial infarction

Autor: Crossman David C, Seo David, Haynes Carol, Wang Ty, Lou Xuemei, Hale A Brent, Crosslin David R, Nelson Sarah, Gadson Shera, Doss Jennifer F, Shah Svati H, Connelly Jessica J, Mooser Vincent, Granger Christopher B, Jones Christopher JH, Kraus William E, Hauser Elizabeth R, Gregory Simon G

Publikováno v: BMC Medical Genetics, Vol 9, Iss 1, p 33 (2008)

Abstract Background We previously identified a 40 Mb region of linkage on chromosome 1q in our early onset coronary artery disease (CAD) genome-wide linkage scan (GENECARD) with modest evidence for linkage (n = 420, LOD 0.95). When the data are strat

Externí odkaz: https://doaj.org/article/9944d1556dc14a139c3bad547030261b

Zobrazit plný text záznamu

Akademický článek

Investigation of the effect of Interleukin-1 receptor antagonist (IL-1ra) on markers of inflammation in non-ST elevation acute coronary syndromes (The MRC-ILA-HEART Study)

Autor: Flather Marcus D, Lucking Andrew J, Fox Keith AA, Hall Alistair S, Greenwood John P, Gunn Julian P, Morton Allison C, Crossman David C, Lees Belinda, Foley Claire E

Publikováno v: Trials, Vol 9, Iss 1, p 8 (2008)

Abstract Background Acute Coronary Syndromes account for 15% of deaths in the UK, and patients remain at significant risk of re-admission for future complications and death. Pathologically the underlying process of atherosclerosis is driven by inflam

Externí odkaz: https://doaj.org/article/d22a0b6eb03c4c5b92f838470da7d4f3

Zobrazit plný text záznamu

Effect of Transcatheter Aortic Valve Implantation vs Surgical Aortic Valve Replacement on All-Cause Mortality in Patients With Aortic Stenosis: A Randomized Clinical Trial

Autor: Toff, William D., Hildick-Smith, David, Kovac, Jan, Mullen, Michael J., Wendler, Olaf, Mansouri, Anita, Rombach, Ines, Abrams, Keith R., Conroy, Simon P., Flather, Marcus D., Gray, Alastair M., MacCarthy, Philip, Monaghan, Mark J., Prendergast, Bernard, Ray, Simon, Young, Christopher P., Crossman, David C., Cleland, John G. F., de Belder, Mark A., Ludman, Peter F., Jones, Stephen, Densem, Cameron G., Tsui, Steven, Kuduvalli, Manoj, Mills, Joseph D., Banning, Adrian P., Sayeed, Rana, Hasan, Ragheb, Fraser, Douglas G. W., Trivedi, Uday, Davies, Simon W., Duncan, Alison, Curzen, Nick, Ohri, Sunil K., Malkin, Christopher J., Kaul, Pankaj, Muir, Douglas F., Owens, W. Andrew, Uren, Neal G., Pessotto, Renzo, Kennon, Simon, Awad, Wael I., Khogali, Saib S., Matuszewski, Maciej, Edwards, Richard J., Ramesh, Bandigowdanapalya C., Dalby, Miles, Raja, Shahzad G., Mariscalco, Giovanni, Lloyd, Clinton, Cox, Ian D., Redwood, Simon R., Gunning, Mark G., Ridley, Paul D.

Publikováno v: JAMA

IMPORTANCE: Transcatheter aortic valve implantation (TAVI) is a less invasive alternative to surgical aortic valve replacement and is the treatment of choice for patients at high operative risk. The role of TAVI in patients at lower risk is unclear.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44665c66754a0dd0542fc59ba6aa0af3
https://europepmc.org/articles/PMC9115619/